Page last updated: 2024-08-24

liarozole and bromochloroacetic acid

liarozole has been researched along with bromochloroacetic acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borghgraef, P; Coene, MC; Cools, W; Goossens, J; Janssen, PA; Stoppie, P; Van Nyen, G; Van Wauwe, J	1
Borgers, M; Coene, MC; Daneels, G; De Coster, R; Moeremans, M; Ramaekers, FC; Schalken, JA; Smets, G; Van Ginckel, R; Van Wauwe, J	1
Boegheim, PJ; Heremans, AM; Lucker, GP; Steijlen, PM; van de Kerkhof, PC	1

Trials

1 trial(s) available for liarozole and bromochloroacetic acid

Article	Year
Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. The British journal of dermatology, 1997, Volume: 136, Issue:1 Topics: Adolescent; Adult; Aged; Androgen Antagonists; Cytochrome P-450 Enzyme Inhibitors; Follow-Up Studies; Humans; Ichthyosis; Imidazoles; Keratins; Male; Middle Aged; Prospective Studies; Severity of Illness Index	1997

Other Studies

2 other study(ies) available for liarozole and bromochloroacetic acid

Article	Year
Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:2 Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cricetinae; Female; Imidazoles; Injections, Subcutaneous; Keratins; Mesocricetus; Microsomes, Liver; Ovariectomy; Rats; Rats, Inbred Strains; Tretinoin; Vagina	1992
Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. The Prostate, 1995, Volume: 27, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Imidazoles; Immunoblotting; Immunohistochemistry; Keratins; Male; Neoplasm Transplantation; Organ Size; Prostate; Prostatic Neoplasms; Random Allocation; Rats; Rats, Inbred F344; Tretinoin; Tumor Cells, Cultured; Vimentin	1995

Article

Year

Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.

The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:2

Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cricetinae; Female; Imidazoles; Injections, Subcutaneous; Keratins; Mesocricetus; Microsomes, Liver; Ovariectomy; Rats; Rats, Inbred Strains; Tretinoin; Vagina

1992

Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid.

The Prostate, 1995, Volume: 27, Issue:3

Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Imidazoles; Immunoblotting; Immunohistochemistry; Keratins; Male; Neoplasm Transplantation; Organ Size; Prostate; Prostatic Neoplasms; Random Allocation; Rats; Rats, Inbred F344; Tretinoin; Tumor Cells, Cultured; Vimentin

1995